Report Detail

Request for Sample of this report

Pharma & Healthcare Global Bacteria-derived Microbial Drugs Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032

  • RnM4680141
    • |
  • 26 February, 2026
    • |
  • Global
    • |
  • 129 Pages
    • |
  • GIR
    • |
  • Pharma & Healthcare

According to our (Global Info Research) latest study, the global Bacteria-derived Microbial Drugs market size was valued at US$ million in 2025 and is forecast to a readjusted size of US$ million by 2032 with a CAGR of %during review period.
This report is a detailed and comprehensive analysis for global Bacteria-derived Microbial Drugs market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Bacteria-derived Microbial Drugs market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Bacteria-derived Microbial Drugs market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Bacteria-derived Microbial Drugs market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Bacteria-derived Microbial Drugs market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Bacteria-derived Microbial Drugs
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Bacteria-derived Microbial Drugs market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Seres Therapeutics, Assembly Biosciences, Synthetic Biologics, Interxon, PureTech, Synlogic, Enterome BioScience, 4D Pharma, Second Genome, AOBiome, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Bacteria-derived Microbial Drugs market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Oral Dosage Form
Enteric Capsules
Market segment by Application
Gastrointestinal Disorders
Autoimmune Disorders
Diabetes
Cancer
Others
Major players covered
Seres Therapeutics
Assembly Biosciences
Synthetic Biologics
Interxon
PureTech
Synlogic
Enterome BioScience
4D Pharma
Second Genome
AOBiome
Rebiotix
Metabiomics
Ritter Pharmaceuticals
Symberix
OpenBiome
Azitra
Osel
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Bacteria-derived Microbial Drugs product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Bacteria-derived Microbial Drugs, with price, sales quantity, revenue, and global market share of Bacteria-derived Microbial Drugs from 2021 to 2026.
Chapter 3, the Bacteria-derived Microbial Drugs competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Bacteria-derived Microbial Drugs breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Bacteria-derived Microbial Drugs market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Bacteria-derived Microbial Drugs.
Chapter 14 and 15, to describe Bacteria-derived Microbial Drugs sales channel, distributors, customers, research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Bacteria-derived Microbial Drugs Consumption Value by Type: 2021 Versus 2025 Versus 2032
    • 1.3.2 Oral Dosage Form
    • 1.3.3 Enteric Capsules
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Bacteria-derived Microbial Drugs Consumption Value by Application: 2021 Versus 2025 Versus 2032
    • 1.4.2 Gastrointestinal Disorders
    • 1.4.3 Autoimmune Disorders
    • 1.4.4 Diabetes
    • 1.4.5 Cancer
    • 1.4.6 Others
  • 1.5 Global Bacteria-derived Microbial Drugs Market Size & Forecast
    • 1.5.1 Global Bacteria-derived Microbial Drugs Consumption Value (2021 & 2025 & 2032)
    • 1.5.2 Global Bacteria-derived Microbial Drugs Sales Quantity (2021-2032)
    • 1.5.3 Global Bacteria-derived Microbial Drugs Average Price (2021-2032)

2 Manufacturers Profiles

  • 2.1 Seres Therapeutics
    • 2.1.1 Seres Therapeutics Details
    • 2.1.2 Seres Therapeutics Major Business
    • 2.1.3 Seres Therapeutics Bacteria-derived Microbial Drugs Product and Services
    • 2.1.4 Seres Therapeutics Bacteria-derived Microbial Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.1.5 Seres Therapeutics Recent Developments/Updates
  • 2.2 Assembly Biosciences
    • 2.2.1 Assembly Biosciences Details
    • 2.2.2 Assembly Biosciences Major Business
    • 2.2.3 Assembly Biosciences Bacteria-derived Microbial Drugs Product and Services
    • 2.2.4 Assembly Biosciences Bacteria-derived Microbial Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.2.5 Assembly Biosciences Recent Developments/Updates
  • 2.3 Synthetic Biologics
    • 2.3.1 Synthetic Biologics Details
    • 2.3.2 Synthetic Biologics Major Business
    • 2.3.3 Synthetic Biologics Bacteria-derived Microbial Drugs Product and Services
    • 2.3.4 Synthetic Biologics Bacteria-derived Microbial Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.3.5 Synthetic Biologics Recent Developments/Updates
  • 2.4 Interxon
    • 2.4.1 Interxon Details
    • 2.4.2 Interxon Major Business
    • 2.4.3 Interxon Bacteria-derived Microbial Drugs Product and Services
    • 2.4.4 Interxon Bacteria-derived Microbial Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.4.5 Interxon Recent Developments/Updates
  • 2.5 PureTech
    • 2.5.1 PureTech Details
    • 2.5.2 PureTech Major Business
    • 2.5.3 PureTech Bacteria-derived Microbial Drugs Product and Services
    • 2.5.4 PureTech Bacteria-derived Microbial Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.5.5 PureTech Recent Developments/Updates
  • 2.6 Synlogic
    • 2.6.1 Synlogic Details
    • 2.6.2 Synlogic Major Business
    • 2.6.3 Synlogic Bacteria-derived Microbial Drugs Product and Services
    • 2.6.4 Synlogic Bacteria-derived Microbial Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.6.5 Synlogic Recent Developments/Updates
  • 2.7 Enterome BioScience
    • 2.7.1 Enterome BioScience Details
    • 2.7.2 Enterome BioScience Major Business
    • 2.7.3 Enterome BioScience Bacteria-derived Microbial Drugs Product and Services
    • 2.7.4 Enterome BioScience Bacteria-derived Microbial Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.7.5 Enterome BioScience Recent Developments/Updates
  • 2.8 4D Pharma
    • 2.8.1 4D Pharma Details
    • 2.8.2 4D Pharma Major Business
    • 2.8.3 4D Pharma Bacteria-derived Microbial Drugs Product and Services
    • 2.8.4 4D Pharma Bacteria-derived Microbial Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.8.5 4D Pharma Recent Developments/Updates
  • 2.9 Second Genome
    • 2.9.1 Second Genome Details
    • 2.9.2 Second Genome Major Business
    • 2.9.3 Second Genome Bacteria-derived Microbial Drugs Product and Services
    • 2.9.4 Second Genome Bacteria-derived Microbial Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.9.5 Second Genome Recent Developments/Updates
  • 2.10 AOBiome
    • 2.10.1 AOBiome Details
    • 2.10.2 AOBiome Major Business
    • 2.10.3 AOBiome Bacteria-derived Microbial Drugs Product and Services
    • 2.10.4 AOBiome Bacteria-derived Microbial Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.10.5 AOBiome Recent Developments/Updates
  • 2.11 Rebiotix
    • 2.11.1 Rebiotix Details
    • 2.11.2 Rebiotix Major Business
    • 2.11.3 Rebiotix Bacteria-derived Microbial Drugs Product and Services
    • 2.11.4 Rebiotix Bacteria-derived Microbial Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.11.5 Rebiotix Recent Developments/Updates
  • 2.12 Metabiomics
    • 2.12.1 Metabiomics Details
    • 2.12.2 Metabiomics Major Business
    • 2.12.3 Metabiomics Bacteria-derived Microbial Drugs Product and Services
    • 2.12.4 Metabiomics Bacteria-derived Microbial Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.12.5 Metabiomics Recent Developments/Updates
  • 2.13 Ritter Pharmaceuticals
    • 2.13.1 Ritter Pharmaceuticals Details
    • 2.13.2 Ritter Pharmaceuticals Major Business
    • 2.13.3 Ritter Pharmaceuticals Bacteria-derived Microbial Drugs Product and Services
    • 2.13.4 Ritter Pharmaceuticals Bacteria-derived Microbial Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.13.5 Ritter Pharmaceuticals Recent Developments/Updates
  • 2.14 Symberix
    • 2.14.1 Symberix Details
    • 2.14.2 Symberix Major Business
    • 2.14.3 Symberix Bacteria-derived Microbial Drugs Product and Services
    • 2.14.4 Symberix Bacteria-derived Microbial Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.14.5 Symberix Recent Developments/Updates
  • 2.15 OpenBiome
    • 2.15.1 OpenBiome Details
    • 2.15.2 OpenBiome Major Business
    • 2.15.3 OpenBiome Bacteria-derived Microbial Drugs Product and Services
    • 2.15.4 OpenBiome Bacteria-derived Microbial Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.15.5 OpenBiome Recent Developments/Updates
  • 2.16 Azitra
    • 2.16.1 Azitra Details
    • 2.16.2 Azitra Major Business
    • 2.16.3 Azitra Bacteria-derived Microbial Drugs Product and Services
    • 2.16.4 Azitra Bacteria-derived Microbial Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.16.5 Azitra Recent Developments/Updates
  • 2.17 Osel
    • 2.17.1 Osel Details
    • 2.17.2 Osel Major Business
    • 2.17.3 Osel Bacteria-derived Microbial Drugs Product and Services
    • 2.17.4 Osel Bacteria-derived Microbial Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.17.5 Osel Recent Developments/Updates

3 Competitive Environment: Bacteria-derived Microbial Drugs by Manufacturer

  • 3.1 Global Bacteria-derived Microbial Drugs Sales Quantity by Manufacturer (2021-2026)
  • 3.2 Global Bacteria-derived Microbial Drugs Revenue by Manufacturer (2021-2026)
  • 3.3 Global Bacteria-derived Microbial Drugs Average Price by Manufacturer (2021-2026)
  • 3.4 Market Share Analysis (2025)
    • 3.4.1 Producer Shipments of Bacteria-derived Microbial Drugs by Manufacturer Revenue ($MM) and Market Share (%): 2025
    • 3.4.2 Top 3 Bacteria-derived Microbial Drugs Manufacturer Market Share in 2025
    • 3.4.3 Top 6 Bacteria-derived Microbial Drugs Manufacturer Market Share in 2025
  • 3.5 Bacteria-derived Microbial Drugs Market: Overall Company Footprint Analysis
    • 3.5.1 Bacteria-derived Microbial Drugs Market: Region Footprint
    • 3.5.2 Bacteria-derived Microbial Drugs Market: Company Product Type Footprint
    • 3.5.3 Bacteria-derived Microbial Drugs Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Bacteria-derived Microbial Drugs Market Size by Region
    • 4.1.1 Global Bacteria-derived Microbial Drugs Sales Quantity by Region (2021-2032)
    • 4.1.2 Global Bacteria-derived Microbial Drugs Consumption Value by Region (2021-2032)
    • 4.1.3 Global Bacteria-derived Microbial Drugs Average Price by Region (2021-2032)
  • 4.2 North America Bacteria-derived Microbial Drugs Consumption Value (2021-2032)
  • 4.3 Europe Bacteria-derived Microbial Drugs Consumption Value (2021-2032)
  • 4.4 Asia-Pacific Bacteria-derived Microbial Drugs Consumption Value (2021-2032)
  • 4.5 South America Bacteria-derived Microbial Drugs Consumption Value (2021-2032)
  • 4.6 Middle East & Africa Bacteria-derived Microbial Drugs Consumption Value (2021-2032)

5 Market Segment by Type

  • 5.1 Global Bacteria-derived Microbial Drugs Sales Quantity by Type (2021-2032)
  • 5.2 Global Bacteria-derived Microbial Drugs Consumption Value by Type (2021-2032)
  • 5.3 Global Bacteria-derived Microbial Drugs Average Price by Type (2021-2032)

6 Market Segment by Application

  • 6.1 Global Bacteria-derived Microbial Drugs Sales Quantity by Application (2021-2032)
  • 6.2 Global Bacteria-derived Microbial Drugs Consumption Value by Application (2021-2032)
  • 6.3 Global Bacteria-derived Microbial Drugs Average Price by Application (2021-2032)

7 North America

  • 7.1 North America Bacteria-derived Microbial Drugs Sales Quantity by Type (2021-2032)
  • 7.2 North America Bacteria-derived Microbial Drugs Sales Quantity by Application (2021-2032)
  • 7.3 North America Bacteria-derived Microbial Drugs Market Size by Country
    • 7.3.1 North America Bacteria-derived Microbial Drugs Sales Quantity by Country (2021-2032)
    • 7.3.2 North America Bacteria-derived Microbial Drugs Consumption Value by Country (2021-2032)
    • 7.3.3 United States Market Size and Forecast (2021-2032)
    • 7.3.4 Canada Market Size and Forecast (2021-2032)
    • 7.3.5 Mexico Market Size and Forecast (2021-2032)

8 Europe

  • 8.1 Europe Bacteria-derived Microbial Drugs Sales Quantity by Type (2021-2032)
  • 8.2 Europe Bacteria-derived Microbial Drugs Sales Quantity by Application (2021-2032)
  • 8.3 Europe Bacteria-derived Microbial Drugs Market Size by Country
    • 8.3.1 Europe Bacteria-derived Microbial Drugs Sales Quantity by Country (2021-2032)
    • 8.3.2 Europe Bacteria-derived Microbial Drugs Consumption Value by Country (2021-2032)
    • 8.3.3 Germany Market Size and Forecast (2021-2032)
    • 8.3.4 France Market Size and Forecast (2021-2032)
    • 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
    • 8.3.6 Russia Market Size and Forecast (2021-2032)
    • 8.3.7 Italy Market Size and Forecast (2021-2032)

9 Asia-Pacific

  • 9.1 Asia-Pacific Bacteria-derived Microbial Drugs Sales Quantity by Type (2021-2032)
  • 9.2 Asia-Pacific Bacteria-derived Microbial Drugs Sales Quantity by Application (2021-2032)
  • 9.3 Asia-Pacific Bacteria-derived Microbial Drugs Market Size by Region
    • 9.3.1 Asia-Pacific Bacteria-derived Microbial Drugs Sales Quantity by Region (2021-2032)
    • 9.3.2 Asia-Pacific Bacteria-derived Microbial Drugs Consumption Value by Region (2021-2032)
    • 9.3.3 China Market Size and Forecast (2021-2032)
    • 9.3.4 Japan Market Size and Forecast (2021-2032)
    • 9.3.5 South Korea Market Size and Forecast (2021-2032)
    • 9.3.6 India Market Size and Forecast (2021-2032)
    • 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
    • 9.3.8 Australia Market Size and Forecast (2021-2032)

10 South America

  • 10.1 South America Bacteria-derived Microbial Drugs Sales Quantity by Type (2021-2032)
  • 10.2 South America Bacteria-derived Microbial Drugs Sales Quantity by Application (2021-2032)
  • 10.3 South America Bacteria-derived Microbial Drugs Market Size by Country
    • 10.3.1 South America Bacteria-derived Microbial Drugs Sales Quantity by Country (2021-2032)
    • 10.3.2 South America Bacteria-derived Microbial Drugs Consumption Value by Country (2021-2032)
    • 10.3.3 Brazil Market Size and Forecast (2021-2032)
    • 10.3.4 Argentina Market Size and Forecast (2021-2032)

11 Middle East & Africa

  • 11.1 Middle East & Africa Bacteria-derived Microbial Drugs Sales Quantity by Type (2021-2032)
  • 11.2 Middle East & Africa Bacteria-derived Microbial Drugs Sales Quantity by Application (2021-2032)
  • 11.3 Middle East & Africa Bacteria-derived Microbial Drugs Market Size by Country
    • 11.3.1 Middle East & Africa Bacteria-derived Microbial Drugs Sales Quantity by Country (2021-2032)
    • 11.3.2 Middle East & Africa Bacteria-derived Microbial Drugs Consumption Value by Country (2021-2032)
    • 11.3.3 Turkey Market Size and Forecast (2021-2032)
    • 11.3.4 Egypt Market Size and Forecast (2021-2032)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
    • 11.3.6 South Africa Market Size and Forecast (2021-2032)

12 Market Dynamics

  • 12.1 Bacteria-derived Microbial Drugs Market Drivers
  • 12.2 Bacteria-derived Microbial Drugs Market Restraints
  • 12.3 Bacteria-derived Microbial Drugs Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Bacteria-derived Microbial Drugs and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Bacteria-derived Microbial Drugs
  • 13.3 Bacteria-derived Microbial Drugs Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Bacteria-derived Microbial Drugs Typical Distributors
  • 14.3 Bacteria-derived Microbial Drugs Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on Bacteria-derived Microbial Drugs. Industry analysis & Market Report on Bacteria-derived Microbial Drugs is a syndicated market report, published as Global Bacteria-derived Microbial Drugs Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032. It is complete Research Study and Industry Analysis of Bacteria-derived Microbial Drugs market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    		$3,480.00
    		$5,220.00
    		$6,960.00
    		2,690.04
    		4,035.06
    		5,380.08
    		3,239.88
    		4,859.82
    		6,479.76
    		531,361.20
    		797,041.80
    		1,062,722.40
    		293,712.00
    		440,568.00
    		587,424.00
    Credit card Logo
    Sample Question Discount Download PDF

    Related Reports

    Reason to Buy

    • Trusted By Leaders

      Top executives from leading companies purchase research reports from us. 

    • Shop With Confidence

      We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

    • Customer Centric

      Need assistance related to your research requirements? We are just a phone call or an email away.

    • Personalized Solutions

      Our experienced research specialists are here to help you locate the right reports for your need.

    • Secure Checkout

      Shop without being worried about safety & security of your transactions.
      •

    Request for Sample of this report

    Reports and Markets

    mcafree

    Contact Us

    +1-352-353-0818 (US)

    info@reportsandmarkets.com

    Support

    EMAIL US

    Newsletter

    KEEP UP TO DATE ON ALL THE LATEST REPORTS


    maxmind_logo